ABVC vs ATNM
Comparison between ABVC BioPharma Inc (ABVC, Company) and Actinium Pharmaceuticals Inc (ATNM, Company).
Both ABVC and ATNM are from the Healthcare sector.
5-Year PerformanceATNM has outperformed ABVC, delivering a return of -34.7% compared to -53.0%
ABVC vs ATNM - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
ABVC vs ATNM - Historical Returns
Returns include dividend reinvestment.
ABVC vs ATNM - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | ABVC | ATNM |
|---|---|---|
| 2026 | -45.66% | -26.28% |
| 2025 | +232.14% | +7.94% |
| 2024 | -50.83% | -76.32% |
| 2023 | -80.67% | -49.30% |
| 2022 | -81.34% | +66.41% |
| 2021 | -32.87% | -23.54% |
| 2020 | +1.49% | +9.24% |
| 2019 | -88.44% | -50.03% |
| 2018 | +0.00% | -40.09% |
| 2017 | +0.00% | -27.03% |
| 2016 | -74.88% | -74.26% |
| 2015 | +249920.85% | -44.88% |
| 2014 | +0.00% | -13.00% |
| 2013 | +88.68% | +292.67% |
| 2012 | -94.11% | +0.00% |
| 2011 | -43.75% | N/A |
ABVC vs ATNM Drawdown Comparison
The maximum drawdown for ABVC was -99.97%, occurring on Feb 13, 2025. This drawdown has not yet recovered.
The maximum drawdown for ATNM was -99.75%, occurring on Apr 2, 2026. This drawdown has not yet recovered.
The current ABVC drawdown is -99.92%. The current ATNM drawdown is -99.74%.
| Rank | ABVC | ATNM |
|---|---|---|
| #1 | -99.97% Aug 24, 2015 - Feb 13, 2025 | -99.75% Apr 23, 2014 - Apr 2, 2026 |
| #2 | -99.80% Aug 26, 2011 - Aug 24, 2015 | -58.67% Mar 20, 2013 - Dec 10, 2013 |
| #3 | -89.75% Apr 21, 2011 - Aug 10, 2011 | -32.13% Dec 10, 2013 - Mar 12, 2014 |
| #4 | -62.50% Aug 17, 2011 - Aug 26, 2011 | -11.51% Mar 25, 2014 - Mar 31, 2014 |
| #5 | N/A | -10.70% Apr 3, 2014 - Apr 23, 2014 |
| #6 | N/A | -4.17% Mar 14, 2014 - Mar 25, 2014 |
| #7 | N/A | -0.40% Mar 31, 2014 - Apr 2, 2014 |
Correlation
Correlation between ABVC and ATNM is -0.01 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks